Literature DB >> 8926097

A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.

C S Lachenauer1, L C Madoff.   

Abstract

Infection by group B streptococci (GBS) is an important cause of bacterial disease in neonates, pregnant women, and nonpregnant adults. Historically, serotypes Ia, Ib, II, and III have been most prevalent among disease cases; recently, type V strains have emerged as important strains in the United States and elsewhere. In addition to type-specific capsular polysaccharides, many GBS strains possess surface proteins which demonstrate a laddering pattern on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and resistance to trypsin digestion. These include the alpha C protein, the R proteins, and protein Rib. Some of these proteins elicit protective antibodies in animals. We demonstrate a trypsin-resistant laddering protein purified from a type V GBS strain by mutanolysin extraction and column chromatography. This protein contains a major 90-kDa band and a series of smaller bands spaced approximately 10 kDa apart on SDS-PAGE. Cross-reactivity of the type V protein with the alpha C protein and with R1 was demonstrated on Western blot (immunoblot). N-terminal sequence analysis of the protein revealed residue identity with 17 of 18 residues at corresponding positions on the alpha protein. Western blot of SDS extracts of 41 clinical type V isolates with rabbit antiserum to the protein demonstrated a homologous protein in 25 isolates (61%); two additional strains exhibited a heterologous pattern which was also demonstrated with 4G8, a monoclonal antibody directed to the alpha C protein repeat region. Rabbit antiserum raised to the type V protein conferred protection in neonatal mice against a type V strain bearing a homologous protein. These data support the hypothesis that there exists a family of trypsin-resistant, laddering GBS surface proteins which may play a role in immunity to GBS infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926097      PMCID: PMC174365          DOI: 10.1128/iai.64.10.4255-4260.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group.

Authors:  J D Wenger; A W Hightower; R R Facklam; S Gaventa; C V Broome
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

2.  Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats.

Authors:  S K Hollingshead; V A Fischetti; J R Scott
Journal:  Mol Gen Genet       Date:  1987-05

3.  Antigenicity of group B Streptococcus strain "M9" and its prevalence in Japan.

Authors:  M Sugiyama; Y Nishiyama; Y Yokoo; Y Inazumi; T Murai
Journal:  Kansenshogaku Zasshi       Date:  1990-03

4.  Molecular species of R-protein antigens produced by clinical isolates of group B streptococci.

Authors:  A E Flores; P Ferrieri
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

Authors:  J L Michel; L C Madoff; D E Kling; D L Kasper; F M Ausubel
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  Comparison of streptococcal R antigens.

Authors:  H W Wilkinson
Journal:  Appl Microbiol       Date:  1972-10

7.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

8.  Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.

Authors:  C J Baker; M A Rench; M S Edwards; R J Carpenter; B M Hays; D L Kasper
Journal:  N Engl J Med       Date:  1988-11-03       Impact factor: 91.245

9.  A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci.

Authors:  L C Madoff; J L Michel; D L Kasper
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults.

Authors:  M M Farley; R C Harvey; T Stull; J D Smith; A Schuchat; J D Wenger; D S Stephens
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

View more
  22 in total

1.  Mosaicism in the alpha-like protein genes of group B streptococci.

Authors:  C S Lachenauer; R Creti; J L Michel; L C Madoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

Authors:  C Gravekamp; D L Kasper; L C Paoletti; L C Madoff
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.

Authors:  K M Puopolo; S K Hollingshead; V J Carey; L C Madoff
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Immunological markers of the R4 protein of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

Review 6.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

7.  Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.

Authors:  C Gravekamp; B Rosner; L C Madoff
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Authors:  Augusta I Kvam; Rooyen T Mavenyengwa; Andreas Radtke; Johan A Maeland
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

9.  Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.

Authors:  S R Moyo; J A Maeland; J Mudzori
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

10.  Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes.

Authors:  Roberta Creti; Francesca Fabretti; Graziella Orefici; Christina von Hunolstein
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.